Comparative responsiveness of short-form 12 and Minnesota living with heart failure questionnaire in patients with heart failure

Bonow, 1992, Left ventricular diastolic dysfunction as a cause of congestive heart failure, 502 Guyatt, 1993, Measurement of health-related quality of life in heart failure, J Am Coll Cadiol, 22, 185A, 10.1016/0735-1097(93)90488-M Rector, 1987, Patients' self-assessment of their congestive heart failure: II. Content, reliability and validity of a new measure—the Minnesota Living With Heart Failure Questionnaire, Heart Fail, 3, 198 Ware, 1996, A 12-item short form health survey construction of scales and preliminary tests of reliability and validity, Med Care, 34, 220, 10.1097/00005650-199603000-00003 Ware, 1992, The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002 Kubo, 1992, Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure, Circulation, 85, 942, 10.1161/01.CIR.85.3.942 Rector, 1992, Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan, Am Heart J, 124, 1017, 10.1016/0002-8703(92)90986-6 Rector, 1993, Validity of the Minnesota Living With Heart Failure Questionnaire as a measure of therapeutic response: effects of enalapril and placebo, Am J Cardiol, 71, 106, 10.1016/0002-9149(93)90582-W Jenkinson, 1997, A shorter form health survey: Can the SF-12 replicate results from the SF-36 in longitudinal studies?, J Public Health Med, 19, 179, 10.1093/oxfordjournals.pubmed.a024606 Rich, 1995, A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure, N Engl J Med, 333, 1190, 10.1056/NEJM199511023331806 Fonarow, 1997, Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure, J Am Coll Cardiol, 30, 725, 10.1016/S0735-1097(97)00208-8 West, 1997, A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization, Am J Cardiol, 79, 58, 10.1016/S0002-9149(96)00676-5 Hanumanthu, 1997, Effect of a heart failure program on hospitalization frequency and exercise tolerance, Circulation, 96, 2842, 10.1161/01.CIR.96.9.2842 Binman, 1990, Measuring health changes among severely ill patients, Med Care, 28, 1142, 10.1097/00005650-199012000-00003 Ware, 1995, SF-12: how to score the SF-12 physical and mental health summary scales Fortin, 1995, Measuring relevant change: an emerging challenge in rheumatologic clinical trials, Arthritis Rheum, 38, 1027, 10.1002/art.1780380802 Liang, 1990, Comparisons of five health status instruments for orthopedic evaluation, Med Care, 28, 632, 10.1097/00005650-199007000-00008 Kleinbaum, 1988, The correlation coefficient and straight-line regression analysis, vol. 80, 80 Stucki, 1994, Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis, J Clin Epidemiol, 48, 1369, 10.1016/0895-4356(95)00054-2 Deyo, 1991, Reproducibility and responsiveness of health status measures, 12, 142S Cohen, 1977 Simon, 1998, SF-36 summary score, 36, 567 Rector, 1993, Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life: V-HeFT II, Circulation, 87, V171 Packer, 1996, Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE trial, Circulation, 94, 2793, 10.1161/01.CIR.94.11.2793 Rector, 1998, Measurement of clinical efficacy in studies of heart failure, Circulation, 97, 707, 10.1161/01.CIR.97.7.707 Cowley, 1986, Symptomatic assessment of patients with heart failure: Double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure, Lancet, 2, 770, 10.1016/S0140-6736(86)90298-9 Contadson, 1984, Clinical efficacy of hydralazine in chronic heart failure: One-year double-blind placebo-controlled study, Am Heart J, 108, 1001, 10.1016/0002-8703(84)90467-8